At Cytotheryx we realize that life-saving discovery in liver disease research and medicine requires a multi-faceted approach. The key to enabling this innovation is a reliable foundation. We understand this need and the opportunity to support numerous areas working to advance human health—this is our sole focus.
Our team has developed a revolutionary bio-incubator capable of propagating high-quality, consistent human hepatocytes (HHCs). With this advancement, the liver research community will have extended access to the quantity of HHCs needed to further research as well as to seek applications for drug therapy, cell and gene therapies, liver assist devices, and even allotransplantation.